Rafii, Michael S <br/><br/>
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.  [electronic resource] 

 -  Alzheimer's & dementia : the journal of the Alzheimer's Association  Sep 2014 
 - 571-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-5279 
<br/><br/><label>Standard No.: </label>10.1016/j.jalz.2013.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--diagnostic imaging<br/>Basal Nucleus of Meynert<br/>Dependovirus--genetics<br/>Feasibility Studies<br/>Female<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Humans<br/>Immunohistochemistry<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Nerve Growth Factor--genetics<br/>Neuropsychological Tests<br/>Neurosurgical Procedures<br/>Positron-Emission Tomography<br/>Stereotaxic Techniques<br/>Treatment Outcome